Rachel Klemovitch, Assistant Editor06.25.24
Clarius Mobile Health has gained FDA clearance for the Clarius OB AI fetal biometric measurement tool.
The tool aims to improve access to obstetrical (OB) prenatal monitoring and care in resource-limited areas. The OB AI model automatically performs fetal biometry measurements to estimate fetal age, weight, and growth intervals and is available now with the Clarius C3 HD3 wireless handheld ultrasound scanner in the United States and Canada.
"OB AI is a testament to Clarius' commitment to innovation in the handheld ultrasound market," said Clarius President and CEO Ohad Arazi. "Our mission is to make high-quality ultrasound technology accessible and user-friendly, and with OB AI we're pleased to be helping more clinicians provide accurate and efficient prenatal assessments, ultimately improving maternal and fetal health outcomes."
Clarius C3 HD3 was developed with state-of-the-art learning models, leveraging over 30,000 de-identified fetal ultrasound images. The tool provides consistent and precise measurements.
By integrating AI with affordable and specialized ultrasound technology, Clarius aims to broaden ultrasound access for midwives and nurses, to help improve maternal and fetal health outcomes.
OB AI is included with Clarius membership. Once activated on the Clarius app while a clinician is scanning the abdomen, OB AI automatically highlights key fetal anatomy and places calipers to calculate measurements. These measurements appear on the screen and can be added to a patient's electronic record from the app.
Clarius OB AI is the 8th AI model developed in-house that is available with other Clarius ultrasound scanners.
The tool aims to improve access to obstetrical (OB) prenatal monitoring and care in resource-limited areas. The OB AI model automatically performs fetal biometry measurements to estimate fetal age, weight, and growth intervals and is available now with the Clarius C3 HD3 wireless handheld ultrasound scanner in the United States and Canada.
"OB AI is a testament to Clarius' commitment to innovation in the handheld ultrasound market," said Clarius President and CEO Ohad Arazi. "Our mission is to make high-quality ultrasound technology accessible and user-friendly, and with OB AI we're pleased to be helping more clinicians provide accurate and efficient prenatal assessments, ultimately improving maternal and fetal health outcomes."
Clarius C3 HD3 was developed with state-of-the-art learning models, leveraging over 30,000 de-identified fetal ultrasound images. The tool provides consistent and precise measurements.
By integrating AI with affordable and specialized ultrasound technology, Clarius aims to broaden ultrasound access for midwives and nurses, to help improve maternal and fetal health outcomes.
OB AI is included with Clarius membership. Once activated on the Clarius app while a clinician is scanning the abdomen, OB AI automatically highlights key fetal anatomy and places calipers to calculate measurements. These measurements appear on the screen and can be added to a patient's electronic record from the app.
Clarius OB AI is the 8th AI model developed in-house that is available with other Clarius ultrasound scanners.